Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...

Research and development expenses decreased by $21.7 million to $15.1 million for year ended December 31, 2024, as compared to $36.8 million for the comparable period in 2023. Changes to the ...

In his resignation letter, Marks rebuked Kennedy for seeking “subservient confirmation of his misinformation and lies” about vaccines.

The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...

Investment analysts at StockNews.com assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “sell” rating on ...

Shares of Incyte Co. (NASDAQ:INCY – Get Free Report) have been given a consensus recommendation of “Hold” by the nineteen ...

Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

This season, the New Braunfels baseball team has two players who have bonded over an experience far more challenging than ...

The Cuban Ministry of Public Health (MINSAP) publicly defended the medical attention provided to young Damir Ortiz at the ...

My patients — and my family and friends — often ask me what they can do to reduce their risk of cancer. I’m an oncologist and ...

Audrey’s Children, a feature-length biopic about Audrey Evans, a pioneering British American pediatric oncologist and a ...